Literature DB >> 12957691

Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction.

Shinji Koba1, Tsutomu Hirano, Satoru Murayama, Tomomi Kotani, Fumiyosi Tsunoda, Yoshitaka Iso, Yoshihisa Ban, Takeshi Kondo, Hiroshi Suzuki, Takashi Katagiri.   

Abstract

BACKGROUND: The small dense low-density lipoprotein (LDL) phenotype (pattern B), high concentrations of remnant-like particles (RLPs), and postprandial lipemia are newly recognized risk factors for coronary heart disease (CHD). However, the associations of these lipoprotein abnormalities remain unclear. The aim of this study was to investigate the relationships among LDL phenotype, very-low-density lipoprotein (VLDL) subclasses, and postprandial lipoprotein metabolism in CHD patients.
METHOD: We performed an oral fat tolerance test in 32 patients with acute myocardial infarction and compared the following parameters between patients characterized by either large buoyant LDL (pattern A) versus pattern B: lipids and apolipoproteins (apo) in the plasma and Svedberg flotation rates (Sf) >400 (chylomicron), Sf 60-400 (large VLDL), and Sf 20-60 (small VLDL) fractions. RESULT: Fasting levels of triglyceride, RLP-cholesterol and RLP-triglyceride were slightly higher in the pattern B patients. Postprandial increases of RLP-cholesterol and the cholesterol and triglyceride of large VLDL fractions were significantly greater in the pattern B patients. The areas under the curves of cholesterol, triglyceride, and apo-B in large VLDL fractions were significantly higher in pattern B, while those in small VLDL were not. RLP-cholesterol and RLP-triglyceride in fasting and fed states correlated very highly with the corresponding cholesterol and triglyceride concentrations in large VLDL fractions.
CONCLUSION: These results suggest that postprandial increase of large VLDL fractions and RLPs contribute to the formation of small dense LDL in CHD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957691     DOI: 10.1016/s0021-9150(03)00245-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Lipoproteins: When size really matters.

Authors:  J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  Curr Opin Colloid Interface Sci       Date:  2006-06       Impact factor: 6.448

2.  Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.

Authors:  Yutaka Mori; Genshin Kuriyama; Takaaki Tanaka; Naoko Tajima
Journal:  Endocrine       Date:  2009-10-16       Impact factor: 3.633

3.  Rat adult offspring serum lipoproteins are altered by maternal consumption of a liquid diet.

Authors:  J S Pennington; S N Pennington
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

4.  Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India.

Authors:  Fauzia Ashfaq; P K Goel; Nagraja Moorthy; Rishi Sethi; Mohammed Idrees Khan; Mohammed Zafar Idris
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

5.  The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.

Authors:  K Al Majali; M B Cooper; B Staels; G Luc; M-R Taskinen; D J Betteridge
Journal:  Diabetologia       Date:  2006-01-21       Impact factor: 10.122

6.  Mesenchymal Stem Cell-Derived Extracellular Vesicle-Shuttled microRNA-302d-3p Represses Inflammation and Cardiac Remodeling Following Acute Myocardial Infarction.

Authors:  Yuanyuan Liu; Rongchun Guan; Jizhou Yan; Yueping Zhu; Shiming Sun; Yan Qu
Journal:  J Cardiovasc Transl Res       Date:  2022-02-22       Impact factor: 4.132

7.  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors:  Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora
Journal:  J Clin Lipidol       Date:  2020-02-21       Impact factor: 4.766

8.  Adverse effects of honey on low-density lipoprotein cholesterol and adiponectin concentrations in patients with type 2 diabetes: a randomized controlled cross-over trial.

Authors:  Fatemeh Sadeghi; Masoumeh Akhlaghi; Saedeh Salehi
Journal:  J Diabetes Metab Disord       Date:  2020-04-14

Review 9.  Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases.

Authors:  Takashi Obama; Hiroyuki Itabe
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.